Transmission of pathogens and microorganisms in general is facilitated by many factors
Long-term cardiovascular health, quality of life, safety and the underlying biological mechanisms should all be considered when evaluating future obesity therapies
The Takeaway BPC-157 : experimental, not approved, limited animal data only
Having more active glutathione on board is a good thing for longevity, disease prevention, and the slowing of disease progression
Step 2: Prioritize bioavailable support
Weight-loss medications in the 20th century proved to be equally dangerous: dinitrophenol, a mitochondrial proton pump uncoupler, was remarkably effective at shedding pounds but led to nerve malfunction and arrhythmia induced fatalities